As of close of business last night, Autolus Therapeutics plc ADR’s stock clocked out at $6.33, up 0.16% from its previous closing price of $6.32. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 610749 shares were traded.
Ratios:
To gain a deeper understanding of AUTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.11 and its Current Ratio is at 6.11. In the meantime, Its Debt-to-Equity ratio is 2.01 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on November 09, 2023, initiated with a Buy rating and assigned the stock a target price of $10.
On March 17, 2023, Bryan Garnier started tracking the stock assigning a Buy rating and target price of $5.Bryan Garnier initiated its Buy rating on March 17, 2023, with a $5 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 1.68B and an Enterprise Value of 1.49B. For the stock, the TTM Price-to-Sale (P/S) ratio is 990.20 while its Price-to-Book (P/B) ratio in mrq is 9.89. Its current Enterprise Value per Revenue stands at 879.89 whereas that against EBITDA is -9.53.
Stock Price History:
Over the past 52 weeks, AUTL has reached a high of $7.45, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 6.16, while the 200-Day Moving Average is calculated to be 4.12.
Shares Statistics:
It appears that AUTL traded 1.74M shares on average per day over the past three months and 1.36M shares per day over the past ten days. A total of 265.93M shares are outstanding, with a floating share count of 226.02M. Insiders hold about 15.01% of the company’s shares, while institutions hold 39.88% stake in the company. Shares short for AUTL as of Feb 29, 2024 were 2.77M with a Short Ratio of 1.59, compared to 2.94M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.19% and a Short% of Float of 1.99%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.2 and a low estimate of -$0.28, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.46 and -$1.23 for the fiscal current year, implying an average EPS of -$0.67. EPS for the following year is -$0.57, with 7 analysts recommending between -$0.02 and -$0.95.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for AUTL’s current fiscal year. The highest revenue estimate was $57M, while the lowest revenue estimate was $2.59M, resulting in an average revenue estimate of $43.38M. In the same quarter a year ago, actual revenue was $1.7M, up 2,454.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $97.87M in the next fiscal year. The high estimate is $194.83M and the low estimate is $47.86M. The average revenue growth estimate for next year is up 125.60% from the average revenue estimate for this year.
